Natus Medical Announces Third Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Natus Medical (BABY) Misses Q3 EPS by 2c, Offers Q4 Guidance
October 24, 2018 6:39 AM EDTNatus Medical (NASDAQ: BABY) reported Q3 EPS of $0.40, $0.02 worse than the analyst estimate of $0.42. Revenue for the quarter came in at $130.6 million versus the consensus estimate of $132.92 million.
GUIDANCE:
Natus Medical sees Q4 2018 EPS of $0.48-$0.51, versus the consensus of... More
